Binance Labs: Biotechnology and science are long-term endeavors that require sustained investment, and we are still in the early stages of integrating cryptographic technology.

According to ChainCatcher news, Binance Labs stated on platform X: 'At the DeSci Day event held last week at Binance Labs BUIDLer House in Bangkok, we gathered around 50 like-minded biotechnology and DeSci enthusiasts to exchange ideas and build connections.'

During the 3-hour event, speakers shared insights on various topics ranging from the development of biotechnology to rapamycin and longevity, citizen science, bioDAO, on-chain intellectual property, and AI agents for science. Some well-known bioDAOs also shared exciting updates—VitaDAO launched their first longevity supplement approved by the Thai FDA. HairDAO is scaling up, applying for a second patent, and launching a shampoo that has significant effects on hair loss. We also invited CZ and Vitalik to interact with the community through an open Q&A session and engage with other DeSci founders and builders.

Biotechnology and science are long-term endeavors that require sustained investment, and we are still in the early stages of integrating cryptographic technology with them. We are excited about the potential and enthusiasm in the field of biotechnology, but we also understand that true innovation requires patience, perseverance, and a long-term vision. We are committed to fostering more innovation in the crypto industry, focusing on lasting achievements and impact. At Binance Labs, we focus on investing in cryptographic technology, biotechnology, and artificial intelligence. We always pay attention to the core foundation, dedicated to achieving long-term impact.